Toutes les études
RecrutementPHASE3INTERVENTIONNEL

Cannabidiol for Bipolar Depression (CBD-BD)

This study is investigating a new way to help people with bipolar depression, using a chemical from the cannabis plant called cannabidiol (CBD). Many people with bipolar disorder find their depression difficult to treat, even with existing medicines. While small studies suggest CBD might help with mood, this is the first large study to properly test its safety and effectiveness for bipolar depression. Participants will receive either CBD or a dummy pill (placebo) alongside their usual treatment. Neither you nor the study team will know which you're getting. The study aims to see if CBD can improve depression symptoms, is safe to use, and is well-tolerated by patients aged 19-70 who haven't fully responded to other treatments.

En un coup d'œil

Statut
Recrutement
Phase
PHASE3
Sponsor
University of British Columbia
Objectif d'inscription
360
Démarrer
15 Oct 2023
Achèvement estimé
01 Dec 2030

De quoi parle cette étude ?

Bipolar disorder is a lifelong condition where people experience periods of both very low mood (depression) and very high mood (mania or hypomania). The depressive periods can be particularly difficult and lengthy for many people. While there are treatments available, not everyone finds them effective or can tolerate their side effects. This means that some people are still looking for other ways to feel better.

This study is looking into cannabidiol (CBD), which is a natural chemical found in the cannabis plant. You might have heard about CBD products, but it’s important to know that CBD itself doesn't cause the 'high' associated with cannabis. Some smaller studies have hinted that CBD might help with mood problems in other health conditions, but we don't yet have enough information from big studies to know if it's truly effective and safe specifically for bipolar depression.

The main goal of this study is to find out if adding CBD to your current treatment can help improve symptoms of bipolar depression. We also want to check if it's safe and if people can tolerate it well. We'll be comparing CBD to a 'placebo', which is a dummy pill that looks exactly like the CBD but contains no active ingredient. This helps us understand if any improvements are truly due to CBD or other factors.

Points clés

  • This study evaluates CBD for bipolar depression in adults (19-70).
  • It compares CBD to a dummy pill (placebo) alongside existing treatments.
  • The goal is to determine CBD's effectiveness, safety, and tolerability for this condition.
  • Participation involves 5 clinic visits and 1 phone call over 10 weeks.
  • You will continue to take your prescribed mood stabilisers or antipsychotics.
  • You won't know if you're receiving CBD or the placebo, and you can leave the study at any time.

Qui peut être éligible ?

This study is looking for men and women between the ages of 19 and 70 (inclusive) who have been diagnosed with Bipolar Disorder Type I or Type II and are currently experiencing a major depressive episode. You also need to be taking an appropriate steady dose of at least one mood-stabilising medication (like lithium or certain antipsychotics) for your bipolar disorder.

To be eligible, you must have already tried at least one standard treatment for your bipolar depression for at least 6 weeks, but it hasn't fully worked for you. We'll also use specific questionnaires to make sure your depression symptoms are at a certain level and your high mood symptoms are not too severe. You can be an inpatient or an outpatient to participate.

If you are a woman who could become pregnant, you will need to agree to use effective birth control methods (like hormonal contraception, IUDs, or double barrier methods) or agree not to have sex during the study period. This is to ensure the safety of any potential pregnancy.

Cet étude pourrait-elle vous convenir ?

Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.

  1. Are you between 19 and 70 years old?
  2. Do you have Bipolar Disorder Type I or Type II and are currently feeling depressed?
  3. Are you currently taking a steady dose of medication for your bipolar disorder (like a mood stabiliser or antipsychotic)?
  4. Have you tried at least one standard treatment for your bipolar depression that hasn't fully helped?
  5. If you are a woman, are you willing to use effective birth control or abstain from sex during the study?
Répondez à chaque question pour voir votre résultat.

En quoi consiste la participation ?

If you decide to take part, you'll be in the study for about 10 weeks. For the main treatment part, which lasts 6 weeks, you'll be randomly given either CBD or a dummy pill (placebo) to take alongside your current bipolar medication. It's like flipping a coin to decide, and neither you nor the study team will know which one you're receiving.

You'll have a total of 5 in-person appointments at the clinic over these 10 weeks, plus one phone call towards the end. These appointments will involve checking your progress, asking about your mood and how you're feeling, and making sure you're tolerating the study medication well. After the 6-week treatment period, there will be one final phone call two weeks later to check on your overall well-being. Throughout the study, you will continue with any mood-stabilising medication you are currently prescribed by your own doctor.

Risques et avantages potentiels

Participating in this study might offer some potential benefits, perhaps by helping to improve your depression symptoms if CBD is found to be effective for you. However, as with all medications, there's always a chance of side effects, even with a placebo. We will carefully monitor your health throughout the study to ensure your safety. It's very important to remember that joining a clinical trial is always voluntary, and you have the right to withdraw at any time for any reason, without it affecting your medical care.

Emplacements (6)

  • UBC Mood Disorders Centre
    Code postal vérifié
    Vancouver, Canada· Recrutement
  • St. Joseph's Healthcare
    Code postal vérifié
    Hamilton, Canada· Recrutement
  • Providence Care Hospital
    Code postal vérifié
    Kingston, Canada· Recrutement
  • Centre des sciences de la santé Sunnybrook
    Code postal vérifié
    Toronto, Canada· Pas encore en recrutement
  • Centre for Addiction and Mental Health (CAMH)
    Code postal vérifié
    Toronto, Canada· Pas encore en recrutement
  • Douglas Mental Health University Institute
    Code postal vérifié
    Montréal, Canada· Pas encore en recrutement

Questions fréquentes

What is cannabidiol (CBD)?

CBD is a chemical found in the cannabis plant. It's different from the part of cannabis that causes a 'high' and is being studied for its potential health benefits.

Qu'est-ce qu'un 'placebo' ?

A placebo is a dummy pill that looks exactly like the study medication but contains no active ingredients. It helps us compare the effects of the actual treatment.

Will I know if I'm getting CBD or the placebo?

No, this is a 'double-blind' study, meaning neither you nor the study team will know if you're taking CBD or the placebo until after the study is over.

Can I stop my regular bipolar medication if I join the study?

No, you will continue to take your prescribed mood-stabilising medication throughout the study as directed by your own doctor.

Combien de temps serai-je impliqué dans l'étude ?

You'll be involved for about 10 weeks in total, with the main treatment part lasting for 6 weeks.

Comment en savoir plus

Nazlin Walji, BSc

Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.

Intéressé à participer ?

Inscrivez votre intérêt

Partagez vos coordonnées et l'équipe de recherche pour "Cannabidiol for Bipolar Depression (CBD-BD)… vous contactera si vous êtes éligible. Consultez toujours votre médecin avant d'accepter de participer.

Discussion

Discussion communautaire

Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.